FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292707820> ?p ?o ?g. }

• W4292707820 endingPage "1904" @default.
• W4292707820 startingPage "1895" @default.
• W4292707820 abstract "Abstract Purpose The purpose of this prospective randomized clinical trial is to compare the clinical outcomes of three injections of leucocyte-poor platelet-rich plasma (LP-PRP) and hyaluronic acid (HA) to a single dose of autologous microfragmented adipose tissue (AMAT) in patients with mild osteoarthritis at a two-year follow-up. Methods Eighty symptomatic knees in fifty patients (mean age: 62.38 ± 11.88 years) with Kellgren-Lawrence grade 0 to 2 osteoarthritis were non blinded, randomly allocated into two equal groups. Group 1 consisted of 40 knees that received autologous LP-PRP + HA; Group 2 consisted of 40 knees treated with a single dose of AMAT injection. The outcomes were measured by Tegner, Marx, Visual Analogue Scale (VAS) for pain, International Knee Documentation Committee, and Knee Injury and Osteoarthritis Outcome Score (KOOS) at 6 (T 1 ), 12 (T 2 ), and 24 (T 3 ) months. Adverse events were recorded at each follow-up timepoint. To assess score differences among subjects of the same gender and age, a subgroup analysis was performed. Results Both groups had significant clinical and functional improvement at 6, 12, and 24 months ( p < 0.05). Comparing the two groups, the AMAT groups showed significantly higher pre-operative Marx score (3.35 ± 4.91 vs. 1.78 ± 3.91) and VAS score (5.03 ± 2.02 vs. 3.85 ± 1.68) ( p < 0.05), higher VAS (3.89 ± 2.51 vs. 2.64 ± 2.00) at T 2 and KOOS-ADL (79.60 ± 20.20 vs. 65.68 ± 23.62), and lower KOOS-Sports (50.30 ± 30.15 vs. 68.35 ± 30.39) at T 3 ( p < 0.05). No patient from either group had experienced major adverse effects. In the LP-PRP group 12 (30%) patients presented swelling, redness, and mild pain for one day after injection and two patients had synovitis for two days and required paracetamol and local ice. In AMAT group 5 (12.5%) patients had ecchymosis and bruising at the fat aspiration site for three days. Conclusion AMAT did not show significant superior clinical improvement compared with three LP-PRP combined with HA injections in terms of functional improvement at different follow-up points. Both procedures were safe with no major complications reporting good results at mid-term follow-up, improving knee function, pain, and quality of live regardless of age and gender. Level of evidence Level I—Prospective Randomized Clinical Trial." @default.
• W4292707820 created "2022-08-23" @default.
• W4292707820 creator A5005509459 @default.
• W4292707820 creator A5043294494 @default.
• W4292707820 creator A5063345999 @default.
• W4292707820 date "2022-08-23" @default.
• W4292707820 modified "2023-09-30" @default.
• W4292707820 title "Autologous microfragmented adipose tissue and leukocyte-poor platelet-rich plasma combined with hyaluronic acid show comparable clinical outcomes for symptomatic early knee osteoarthritis over a two-year follow-up period: a prospective randomized clinical trial" @default.
• W4292707820 cites W1716794597 @default.
• W4292707820 cites W1773219259 @default.
• W4292707820 cites W1981688423 @default.
• W4292707820 cites W2006113857 @default.
• W4292707820 cites W2016695540 @default.
• W4292707820 cites W2030322516 @default.
• W4292707820 cites W2057208793 @default.
• W4292707820 cites W2095069122 @default.
• W4292707820 cites W2102895306 @default.
• W4292707820 cites W2107641904 @default.
• W4292707820 cites W2188441506 @default.
• W4292707820 cites W2195298924 @default.
• W4292707820 cites W2284794714 @default.
• W4292707820 cites W2310491900 @default.
• W4292707820 cites W2317794853 @default.
• W4292707820 cites W2487589095 @default.
• W4292707820 cites W2564076023 @default.
• W4292707820 cites W2582002924 @default.
• W4292707820 cites W2608209876 @default.
• W4292707820 cites W2625921994 @default.
• W4292707820 cites W2746131708 @default.
• W4292707820 cites W2760915372 @default.
• W4292707820 cites W2770411501 @default.
• W4292707820 cites W2781620608 @default.
• W4292707820 cites W2810943605 @default.
• W4292707820 cites W2852757835 @default.
• W4292707820 cites W2883778763 @default.
• W4292707820 cites W2919999424 @default.
• W4292707820 cites W2948013203 @default.
• W4292707820 cites W2950428628 @default.
• W4292707820 cites W2973797420 @default.
• W4292707820 cites W3006030821 @default.
• W4292707820 cites W3016769778 @default.
• W4292707820 cites W3082415461 @default.
• W4292707820 cites W3120411185 @default.
• W4292707820 cites W3133924611 @default.
• W4292707820 cites W3157890546 @default.
• W4292707820 cites W3162978949 @default.
• W4292707820 cites W3191120826 @default.
• W4292707820 cites W3212272353 @default.
• W4292707820 cites W4210648809 @default.
• W4292707820 cites W4236805817 @default.
• W4292707820 doi "https://doi.org/10.1007/s00590-022-03356-2" @default.
• W4292707820 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35997833" @default.
• W4292707820 hasPublicationYear "2022" @default.
• W4292707820 type Work @default.
• W4292707820 citedByCount "3" @default.
• W4292707820 countsByYear W42927078202023 @default.
• W4292707820 crossrefType "journal-article" @default.
• W4292707820 hasAuthorship W4292707820A5005509459 @default.
• W4292707820 hasAuthorship W4292707820A5043294494 @default.
• W4292707820 hasAuthorship W4292707820A5063345999 @default.
• W4292707820 hasBestOaLocation W42927078201 @default.
• W4292707820 hasConcept C105702510 @default.
• W4292707820 hasConcept C126322002 @default.
• W4292707820 hasConcept C141071460 @default.
• W4292707820 hasConcept C14184104 @default.
• W4292707820 hasConcept C142724271 @default.
• W4292707820 hasConcept C168563851 @default.
• W4292707820 hasConcept C188816634 @default.
• W4292707820 hasConcept C197934379 @default.
• W4292707820 hasConcept C204787440 @default.
• W4292707820 hasConcept C2776164576 @default.
• W4292707820 hasConcept C2777529286 @default.
• W4292707820 hasConcept C2780076745 @default.
• W4292707820 hasConcept C535046627 @default.
• W4292707820 hasConcept C71924100 @default.
• W4292707820 hasConcept C89560881 @default.
• W4292707820 hasConceptScore W4292707820C105702510 @default.
• W4292707820 hasConceptScore W4292707820C126322002 @default.
• W4292707820 hasConceptScore W4292707820C141071460 @default.
• W4292707820 hasConceptScore W4292707820C14184104 @default.
• W4292707820 hasConceptScore W4292707820C142724271 @default.
• W4292707820 hasConceptScore W4292707820C168563851 @default.
• W4292707820 hasConceptScore W4292707820C188816634 @default.
• W4292707820 hasConceptScore W4292707820C197934379 @default.
• W4292707820 hasConceptScore W4292707820C204787440 @default.
• W4292707820 hasConceptScore W4292707820C2776164576 @default.
• W4292707820 hasConceptScore W4292707820C2777529286 @default.
• W4292707820 hasConceptScore W4292707820C2780076745 @default.
• W4292707820 hasConceptScore W4292707820C535046627 @default.
• W4292707820 hasConceptScore W4292707820C71924100 @default.
• W4292707820 hasConceptScore W4292707820C89560881 @default.
• W4292707820 hasFunder F4320313475 @default.
• W4292707820 hasIssue "5" @default.
• W4292707820 hasLocation W42927078201 @default.
• W4292707820 hasLocation W42927078202 @default.
• W4292707820 hasLocation W42927078203 @default.
• W4292707820 hasOpenAccess W4292707820 @default.
• W4292707820 hasPrimaryLocation W42927078201 @default.

• next